|
2023 Journal Article Corrigendum to “Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis” [Crit Care Resusc 23(3) (2021) 273–284]Billot, Laurent, Lipman, Jeffrey, Brett, Stephen J., De Waele, Jan J., Cotta, Menino Osbert, Davis, Joshua S., Finfer, Simon, Hammond, Naomi, Knowles, Serena, McGuinness, Shay, Myburgh, John, Paterson, David L., Peake, Sandra, Rajbhandari, Dorrilyn, Rhodes, Andrew, Roberts, Jason A., Roger, Claire, Shirwadkar, Charudatt, Starr, Therese, Taylor, Colman and Dulhunty, Joel M. (2023). Corrigendum to “Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis” [Crit Care Resusc 23(3) (2021) 273–284]. Critical Care and Resuscitation, 25 (1), 60-60. doi: 10.1016/j.ccrj.2023.04.012 |
|
2023 Conference Publication Does renal replacement therapy impact the clearance of meropenem, piperacillin, tazobactam and vancomycin in a critically ill child? An ex vivo studyCree, Michele, Schlapbach, Luregn, Sumi, Chandra, Wallis, Steve, Roberts, Jason and Parker, Suzanne (2023). Does renal replacement therapy impact the clearance of meropenem, piperacillin, tazobactam and vancomycin in a critically ill child? An ex vivo study. ANZICS/ACCCN Intensive Care Annual Scientific Meeting, Adelaide, SA Australia, 29-31 March 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.aucc.2023.07.020 |
|
2023 Journal Article A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU studyRoberts, Jason A., Sime, Fekade, Lipman, Jeffrey, Hernández-Mitre, Maria Patricia, Baptista, João Pedro, Brüggemann, Roger J., Darvall, Jai, De Waele, Jan J., Dimopoulos, George, Lefrant, Jean-Yves, Mat Nor, Mohd Basri, Rello, Jordi, Seoane, Leonardo, Slavin, Monica A., Valkonen, Miia, Venditti, Mario, Wong, Wai Tat, Zeitlinger, Markus and Roger, Claire (2023). A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study. Critical Care and Resuscitation, 25 (1), 1-5. doi: 10.1016/j.ccrj.2023.04.002 |
|
2023 Journal Article Population pharmacokinetics and dosing simulations of ampicillin and sulbactam in hospitalised adult patientsSetiawan, Eko, Cotta, Menino Osbert, Abdul-Aziz, Mohd-Hafiz, Widjanarko, Doddy, Sosilya, Hernycane, Lukas, Dwi Lily, Wallis, Steven C., Parker, Suzanne and Roberts, Jason A. (2023). Population pharmacokinetics and dosing simulations of ampicillin and sulbactam in hospitalised adult patients. Clinical Pharmacokinetics, 62 (4), 1-14. doi: 10.1007/s40262-023-01219-5 |
|
2023 Other Outputs TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trialsHernández-Mitre, María Patricia, UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia, Morpeth, Susan C., Venkatesh, Balasubramanian, Hills, Thomas E., Davis, Joshua, Mahar, Robert K., McPhee, Grace, Jones, Mark, Totterdell, James, Tong, Steven Y. C. and Roberts, Jason A. (2023). TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols. doi: 10.37766/inplasy2023.2.0120 |
|
2023 Journal Article Treatment Failure Due to Adaptive Resistance Mechanisms in a Severe and Complicated Bloodstream Infection Due toStewart, Adam G., Roberts, Jason A., Forde, Brian M., Bergh, Haakon, Kidd, Timothy J., Wright, Hugh and Harris, Patrick N. A. (2023). Treatment Failure Due to Adaptive Resistance Mechanisms in a Severe and Complicated Bloodstream Infection Due to . Microbial Drug Resistance, 29 (4), 145-149. doi: 10.1089/mdr.2022.0179 |
|
2023 Journal Article Population pharmacokinetics of ganciclovir in allogeneic hematopoietic stem cell transplant patientsSelby, Philip R., Heffernan, Aaron J., Yeung, David, Warner, Morgyn S., Peake, Sandra L., Hahn, Uwe, Wallis, Steven C., Mcwhinney, Brett, Ungerer, Jacobus P. J., Shakib, Sepehr and Roberts, Jason A. (2023). Population pharmacokinetics of ganciclovir in allogeneic hematopoietic stem cell transplant patients. Antimicrobial Agents and Chemotherapy, 67 (3), 1-13. doi: 10.1128/aac.01550-22 |
|
2023 Journal Article Population pharmacokinetic and pharmacodynamic analysis of valganciclovir for optimizing preemptive therapy of cytomegalovirus infections in kidney transplant recipientsCojutti, Pier Giorgio, Heffernan, Aaron J., Tängdén, Thomas, Della Siega, Paola, Tascini, Carlo, Roberts, Jason A. and Pea, Federico (2023). Population pharmacokinetic and pharmacodynamic analysis of valganciclovir for optimizing preemptive therapy of cytomegalovirus infections in kidney transplant recipients. Antimicrobial Agents and Chemotherapy, 67 (3), e0166522. doi: 10.1128/aac.01665-22 |
|
2023 Journal Article Fingerprick microsampling methods can replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid, and prednisolone concentrations in adult kidney transplant patientsScuderi, Carla, Parker, Suzanne, Jacks, Margaret, John, George T., McWhinney, Brett, Ungerer, Jacobus, Mallett, Andrew, Healy, Helen, Roberts, Jason and Staatz, Christine (2023). Fingerprick microsampling methods can replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid, and prednisolone concentrations in adult kidney transplant patients. Therapeutic Drug Monitoring, 45 (1), 69-78. doi: 10.1097/FTD.0000000000001024 |
|
2023 Journal Article Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patientsChai, Ming G, Roberts, Jason A, Farkas, Andras and Cotta, Menino O (2023). Accuracy of a precision dosing software program for predicting antibiotic concentrations in critically ill patients. Journal of Antimicrobial Chemotherapy, 78 (2), 354-358. doi: 10.1093/jac/dkac392 |
|
2023 Journal Article Antimicrobial residual drug error in the intensive care unit; a single blinded prospective observational studyJarrett, Paul, Keogh, Samantha, Roberts, Jason A., Wallis, Steven C. and Coyer, Fiona M. (2023). Antimicrobial residual drug error in the intensive care unit; a single blinded prospective observational study. Intensive and Critical Care Nursing, 77 103403, 103403. doi: 10.1016/j.iccn.2023.103403 |
|
2023 Journal Article Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae—authors’ responseSumi, Chandra Datta, Roberts, Jason A and Sime, Fekade B (2023). Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae—authors’ response. Journal of Antimicrobial Chemotherapy, 78 (3), 854-857. doi: 10.1093/jac/dkad017 |
|
2023 Journal Article Precision medicine in the ICU: One size fits one patientBarletta, Jeffrey F. and Roberts, Jason A. (2023). Precision medicine in the ICU: One size fits one patient. Pharmacotherapy, 43 (11), 1100-1101. doi: 10.1002/phar.2886 |
|
2023 Journal Article Antimicrobial exposures in critically ill patients receiving extracorporeal membrane oxygenationShekar, Kiran, Abdul-Aziz, Mohd H, Cheng, Vesa, Burrows, Fay, Buscher, Hergen, Cho, Young-Jae, Corley, Amanda, Diehl, Arne, Gilder, Eileen, Jakob, Stephan M, Kim, Hyung-Sook, Levkovich, Bianca J, Lim, Sung Yoon, McGuinness, Shay, Parke, Rachael, Pellegrino, Vincent, Que, Yok-Ai, Reynolds, Claire, Rudham, Sam, Wallis, Steven C, Welch, Susan A, Zacharias, David, Fraser, John F. and Roberts, Jason A (2023). Antimicrobial exposures in critically ill patients receiving extracorporeal membrane oxygenation. American Journal of Respiratory and Critical Care Medicine, 207 (6), 704-720. doi: 10.1164/rccm.202207-1393oc |
|
2023 Journal Article Does renal replacement therapy impact the clearance of meropenem, piperacillin, tazobactam and vancomycin in a critically ill child? An ex vivo studyCree, Michele, Schlapbach, Luregn, Sumi, Chandra, Wallis, Steve, Roberts, Jason and Parker, Suzanne (2023). Does renal replacement therapy impact the clearance of meropenem, piperacillin, tazobactam and vancomycin in a critically ill child? An ex vivo study. Australian Critical Care, 36, S4-S5. doi: 10.1016/j.aucc.2023.07.020 |
|
2023 Journal Article Are meropenem, piperacillin, tazobactam and vancomycin sequestered onto a paediatric extracorporeal membrane oxygenation circuit? An ex vivo studyCree, Michele, Haisz, Emma, Sumi, Chandra, Wallis, Steve, Schlapbach, Luregn, Roberts, Jason and Parker, Suzanne (2023). Are meropenem, piperacillin, tazobactam and vancomycin sequestered onto a paediatric extracorporeal membrane oxygenation circuit? An ex vivo study. Australian Critical Care, 36, S5-S6. doi: 10.1016/j.aucc.2023.07.023 |
|
2023 Journal Article Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection modelAbbott, Iain J., van Gorp, Elke, Cottingham, Hugh, Macesic, Nenad, Wallis, Steven C., Roberts, Jason A., Meletiadis, Joseph and Peleg, Anton Y. (2023). Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model. Journal of Antimicrobial Chemotherapy, 78 (2), 397-410. doi: 10.1093/jac/dkac402 |
|
2022 Journal Article Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approachesSelby, Philip R., Warner, Morgyn S., Peake, Sandra L., Bardy, Peter, Hiwase, Devendra, Singhal, Deepak, Beligaswatte, Ashanka, Hahn, Uwe, Roberts, Jason A., Yeung, David and Shakib, Sepehr (2022). Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches. Transplant Infectious Disease, 24 (6) e13988, 1-11. doi: 10.1111/tid.13988 |
|
2022 Journal Article Current and emerging treatment options for multidrug resistant Escherichia coli urosepsis: a reviewWalker, Mikaela M., Roberts, Jason A., Rogers, Benjamin A., Harris, Patrick N. A. and Sime, Fekade B. (2022). Current and emerging treatment options for multidrug resistant Escherichia coli urosepsis: a review. Antibiotics, 11 (12) 1821, 1-20. doi: 10.3390/antibiotics11121821 |
|
2022 Journal Article Anticoagulation strategies in non–critically ill patients with Covid-19McQuilten, Zoe K., Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan C., Totterdell, James A., McPhee, Grace M., Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak K., Barina, Lauren A., Basnet, Bhupendra K., Bhally, Hasan, Bhusal, Khema R., Bogati, Umesh, Bowen, Asha C., Burke, Andrew J., Christopher, Devasahayam J., Chunilal, Sanjeev D., Cochrane, Belinda, Curnow, Jennifer L., Das, Santa Kumar, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, DSouza, Hyjel, Dummer, Jack, Dutta, Sourabh ... Tong, Steven Y.C. (2022). Anticoagulation strategies in non–critically ill patients with Covid-19. NEJM Evidence, 2 (2). doi: 10.1056/evidoa2200293 |
